多発性硬化症（MS）の疫学的予測（～2024）...市場調査レポートについてご紹介

1 Table of Contents
1 Table of Contents 4
1.1 List of Tables 6
1.2 List of Figures 6
2 Introduction 7
2.1 Catalyst 7
2.2 Related Reports 7
2.3 Upcoming Related Reports 7
3 Epidemiology 8
3.1 Disease Background 8
3.2 Risk Factors and Comorbidities 9
3.2.1 Family members of MS patients have a 1-5% risk of developing MS 10
3.2.2 Women are twice as likely to develop MS, but men have a worse prognosis 11
3.2.3 Caucasians have a higher risk of MS than any other race/ethnicity 11
3.2.4 Protective effect of vitamin D on MS may relate to latitude and month of birth 11
3.2.5 Timing of environmental exposures affects MS risk 12
3.2.6 Exposure to smoking may increase MS risk and worsen prognosis 12
3.2.7 Autoimmune diseases are comorbidities of MS 13
3.2.8 Mental comorbidities are found in up to 60% of MS patients and may affect relapse rates 13
3.3 Global Trends 14
3.3.1 North America 14
3.3.2 Europe 15
3.3.3 Asia 15
3.4 Forecast Methodology 16
3.4.1 Sources Used 19
3.4.2 Sources Not Used 25
3.4.3 Forecast Assumptions and Methods 25
3.5 Epidemiological Forecast for MS (2014-2024) 32
3.5.1 Diagnosed Prevalent Cases of MS 32
3.5.2 Age-Specific Diagnosed Prevalent Cases of MS 34
3.5.3 Sex-Specific Diagnosed Prevalent Cases of MS 36
3.5.4 Diagnosed Incident Cases of MS 38
3.5.5 Age-Specific Diagnosed Incident Cases of MS 40
3.5.6 Sex-Specific Diagnosed Incident Cases of MS 42
3.5.7 MS Subtypes 43
3.6 Discussion 44
3.6.1 Epidemiological Forecast Insight 44
3.6.2 Limitations of the Analysis 45
3.6.3 Strengths of the Analysis 45
4 Appendix 46
4.1 Bibliography 46
4.2 About the Authors 53
4.2.1 Epidemiologists 53
4.2.2 Reviewers 54
4.2.3 Global Director of Therapy Analysis and Epidemiology 54
4.2.4 Global Head of Healthcare 55
4.3 About GlobalData 56
4.4 About EpiCast 56
4.5 Disclaimer 57